Kidney Transplantation Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Trans Recip
Conditions: Kidney Transplant; Complications; CMV Interventions: Drug: Letermovir 480 mg once daily; Other: Historical/Control Sponsors: Virginia Commonwealth University; Merck Sharp & Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
Donor Derived Cell-free DNA and Rejection of Kidney Allografts
Condition: Kidney Rejection Transplant Intervention: Diagnostic Test: Donor-derived cell-free DNA Sponsor: Paris Translational Research Center for Organ Transplantation Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2023 Category: Research Source Type: clinical trials